Philip Bonomi to Drug Therapy, Combination
This is a "connection" page, showing publications Philip Bonomi has written about Drug Therapy, Combination.
Connection Strength
0.036
-
A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586). Lung Cancer. 1999 Sep; 25(3):199-206.
Score: 0.010
-
Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas. Cancer Treat Rep. 1978 Aug; 62(8):1211-3.
Score: 0.009
-
Inhibition of cancer cell proliferation by disruption of interdigitated/concatenated hierarchies of metabolic control/implementation processes: a proposal. Med Hypotheses. 1998 Feb; 50(2):119-23.
Score: 0.009
-
Combined modality treatment using BID radiation for locally advanced non-small cell lung carcinoma. Cancer. 1994 May 15; 73(10):2599-606.
Score: 0.007